Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer

NCT02948543 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

501

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: Bacillus of Calmette-Guerin (BCG)
DRUG: Mitomycin (MM)

Sponsor

University of Sydney

Collaborators

[object Object]
[object Object]